Efficacy of Abiraterone and Enzalutamide in Pre- and Postdocetaxel Castration-Resistant Prostate Cancer: A Trial-Level Meta-Analysis

We examined the comparative efficacies of first-line abiraterone and enzalutamide in pre- and postdocetaxel settings in castration-resistant prostate cancer (CRPC) through a trial level meta-analysis. A mixed method approach was applied to 19 unique studies containing 17 median overall survival (OS)...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Mike, Nakazawa, Mary, Antonarakis, Emmanuel S., Li, Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735648/
https://www.ncbi.nlm.nih.gov/pubmed/29359049
http://dx.doi.org/10.1155/2017/8560827

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735648/
https://www.ncbi.nlm.nih.gov/pubmed/29359049
http://dx.doi.org/10.1155/2017/8560827

Ejemplares similares